from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3338/-

LFCtreatmentdescriptionclass of inhibitor

0.026

Amikacinug/mL Amikacintranslation

-0.191

Cap5-10ug/mL Capreomycintranslation

-0.612

Rox10-50 ug/mL Roxithromycintranslation

-0.375

SM2-5 ug/mL Streptomycintranslation

-0.793

Tet5-10 ug/mL Tetracyclinetranslation

1.061

Rif0.2-5ug/mL Rifampicintranscription

0.252

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.080

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.609

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.364

CPZ10-50 ug/mL Chlorpromazinerespiration

0.166

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.293

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.059

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.284

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.503

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.391

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.240

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.965

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.621

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.335

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.152

KCN5-20 ug/mL Potassium cyaniderespiration

-0.195

NaN30.2-2 mM Sodium aziderespiration

-0.795

Nigericin50 uM Nigericinrespiration

0.598

TRC10-150 ug/mL Triclosanrespiration

0.906

TRZ10-25 ug/mL Thioridazinerespiration

0.691

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.249

menadione6-10 ug/mL Menadionerespiration

2.834

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.923

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.456

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.816

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.639

NRP_1Non-replicating persistence stage 1dosRassociated

-0.513

Amp0.2mg/mL AmpicillincellWall

-0.472

Cephalexin20-100 ug/mL CephalexincellWall

-0.999

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.048

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.038

EMB10-20 ug/mL EthambutolcellWall

-0.038

Eta12-40 ug/mL EthionamidecellWall

0.027

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.091

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.746

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.624

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.038

BZA0.12 mg/mL BenzamidearomaticAmides

-0.106

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.481

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.209

H2O24 mM hydrogen peroxideDNAdamaging

-0.741

Levo10 ug/mL LevofloxacinDNAdamaging

-0.296

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.825

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.326

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.612

UVUV-irradiationDNAdamaging

0.172

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.786

Antimycin12.5-50 ug/mL Antimycin A?

-0.579

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.755

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.542

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.499

PA8240.2-2 ug/mL PA-824?

0.951

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.115

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.399

Verapamil50 uM Verapamil?

-0.557

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.568

methoxatin10-20 ug/mL Methoxatin?